Navigation Links
Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City
Date:8/5/2008

"From the Ground Up: Building Comprehensive HIV/AIDS Care Programs in Resource-Limited Settings" Features Work of More Than 230 Global Health Experts

MEXICO CITY, Aug. 5 /PRNewswire-USNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation, with support from the "A Day in the Life of Africa" Foundation/Tides Foundation, the U.S. Government, Harvard University and others, unveiled today a comprehensive guide to improving and expanding HIV/AIDS prevention, care and treatment efforts in resource-limited settings. Dr. Richard Marlink, the Elizabeth Glaser Pediatric AIDS Foundation's Vice President of Program Implementation, led the development of this groundbreaking new resource, and provided a preview of the publication at the International AIDS Society Conference in Mexico City.

From the Ground Up: Building Comprehensive HIV/AIDS Care Programs in Resource-Limited Settings is a three-volume publication containing practical guidance designed and written toward health care providers, managers, policy makers, and implementers, as well as the academic community.

"This guide distills our experiences over the past two decades from a wide range of international HIV/AIDS efforts, with a special focus on sub-Saharan Africa," said Dr. Marlink. "In this new era of expanded funding, a documentation of lessons being learned, in addition to the latest knowledge concerning the evolving 'science' of implementing care programs in resource constrained settings, is critically important."

More than 230 authors from many of the world's leading public health institutions contributed to the text, sharing their first-hand experiences and recommendations for the benefit of the international HIV/AIDS community. All chapters are presented in a practical and accessible format, providing a comprehensive summary of crucial considerations for international HIV/AIDS programs in the 21st century.

"From the Ground Up is a testament to the importance of
'/>"/>

SOURCE Elizabeth Glaser Pediatric AIDS Foundation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
2. Viatronix V3D-Colon Utilized in Another Landmark Study
3. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
4. Hospital Launches Landmark Emergency Medicine Project
5. JACC Identifies DEFER with 5-year Outcomes as Landmark Trial
6. Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population
7. TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial
8. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
9. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
10. Statement From The National Conclave on HIV/AIDS Policy for Black Clergy
11. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...-NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicecompan...surgicaltreatmentsforthespine,announcedtodaythatit...5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfocuson...sproductsandwillincludecommentsfrommanagementfollo...ersare1-877-407-4018fordomesticcallersand1-201-689...
(Date:11/25/2009)...er.comannouncesthatanewmarketresearchreportisavail...USMarketTrends&Analysis http://www.reportlink...et-Trends--Analysis.html ,, TheUSintranasaldru...capplicationsfromthedeliveryofconventionallocalthe...gs.Thefutureofthetechnologyhingesontotheeffectivee...
(Date:11/25/2009)...-- ChemoCentryx,Inc.,announcedtodaythatPhaseII/II...iveRandomizedOralTherapyEvaluationinCrohn,sdisease...erate-to-severeCrohn,sdiseasedemonstratedclinicale...Thestudydemonstratedevidenceofclinicalefficacyinth...reaseintheCrohn,sDiseaseActivityIndex(CDAI)inpatie...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5LSUHSC research identifies enzyme that makes survival molecule for key vision cells 50167 1LSUHSC research identifies enzyme that makes survival molecule for key vision cells 50167 2Taxpayer Alliance applauds bill to broaden access to federal research results 9018 1Taxpayer Alliance applauds bill to broaden access to federal research results 9018 2T STAR grant funds genetic studies on shrimp and papaya and endangered cycad rescue 9016 1T STAR grant funds genetic studies on shrimp and papaya and endangered cycad rescue 9016 2
...ELBOURNE, Australia, Sept. 4 Cytopia Limited (ASX...ment for its Phase Ib/II,study of CYT997, the comp...n patients with an aggressive form of brain cancer... clinical trial is the first Phase II efficacy stu... the company and the second in its,suite of Phase ...
...nother Roche first in TaqMan(R) real-time PCR test... lab, PLEASANTON, Calif., Sept. 4 The U.S. ...Roche COBAS(R) TaqMan(R) HBV Test,the first assay ... the U.S.,The test uses Roche,s real-time PCR tech... DNA in a patient,s blood. Doctors may use viral l...
Other Medicine Technology:Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3
(Date:11/25/2009)...tiative expands to include cost-effective, sustain... healthcare professionals in developing world. , ...ember 25, 2009 -- Elluminate, Inc. , the leader i...ns that support 21st century teaching, learning, ...and Ice initiative was awarded iNACOL,s first-ev...
(Date:11/25/2009)...RNewswire/--dazzlesmile,llc www.dazzlesmile.com an....com havefileda67-pagefederallawsuitagainstEpicAdv...ms,FarendServicesLimited,andAtLastFulfillment.The1...ourtfortheDistrictofUtah,allegesmassivenationalcon...eethwhiteningproducts,violationsoftheRacketeeringI...
(Date:11/25/2009)...in French and Spanish . , , Researchers... early diagnosis of certain ocular diseases that a...degeneration and keratitis, by applying an existin...before been used for this purpose. , Scientists ...ubjects affected by one of these two pathologies, ...
(Date:11/25/2009)...icians at UT Southwestern Medical Center soon will... breathing in patients with upper spinal-cord inju...ng independently. , UT Southwestern University ...n Texas and one of 25 in the country currently equ...hragm Pacing System. , The device is designed to...
(Date:11/25/2009)...ing support for recent enforcement actions against...sociation of Chain Drug Stores (NACDS) submitted a... The letter expresses the Association’s con... foreign, that are engaged in a pattern of illegal... of prescription medications. , ...
Breaking Medicine News(10 mins):Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Achieve early diagnosis of ocular pathologies such as keratitis and macular degeneration 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2Health News:NACDS Supports FDA Enforcement Against Rogue Internet Pharmacy Websites 2
...ld Lester Boggs whose lackadaisical attitude towar... the cause of his death// when he apparently expos...n Sept. 3 at St. John's Hospital marking Sangamon ...virus. Boggs' wife of 66 years, Mary Boggs, ...
...officials have announced a hike of 5.6 percent for...ides this premiums for the wealthier// beneficiari...rst time the federal government has required the a...vering doctor visits and outpatient hospital care,...
... to a Japanese study, there has been a significant...ases, due to drinking of green tea//. A 25 ...sease was reported in this study conducted on more...the diet in the west. The findings of this...
...inflammatory drug colchicine, which is often used ...preventing liver cancer// in patients with hepatit...researchers said in a new study. The study f... the Instituto Nacional de Cancerologia, Mexico Ci...
...he safest pain medication? Many people with osteoa...r studies linked the painkillers called COX-2 inhi...le with arthritis have switched from a COX-2 drug ...ctive at reducing pain and inflammation, they can ...
...vation issue continues to haunt the prestigious Al... as the main poll plank// for the elections to its...ly Tuesday. Nearly 1,400 resident doctors, in... Sixteen Candidates are contesting the elections t...
Other Medicine News:Health News:91-year-old city man Falls Victim to West Nile Virus 2Health News:Medicare Premiums to be Higher Next Year 2Health News:Live long with Green tea!! 2Health News:Live long with Green tea!! 3Health News:AIIMS Goes to Polls Amid Reservation Issues 2
Full Handle Laseredge Implant Blade Knife, 3.2 mm round tip
Full Handle Laseredge Implant Blade Knife, 5.2 mm angled bevel up
Full Handle Laseredge Implant Blade Knife, 4.0 mm angled bevel up
Full Handle Laseredge Crescent Blade Knife, angled bevel down
Medicine Products: